Urgent Action Required!
Click Here See Ad in Wall Street Journal
Defending Bio-Identical Hormones
Recent Editorials and Articles
Defend your Right to Use Bio-identical Hormones
Steven F. Hotze, M.D.
July 02, 2008
Will you join our army and help us recruit 100,000 individuals to contact the U.S. Congress demanding our right to use bio-identical hormones?
Wyeth and the FDA have attacked the rights of patients, pharmacists and physicians who have chosen the safe and natural alternative solution of bio-identical hormones. We are in a life or death struggle. Wyeth has worked in collusion with the FDA to protect its profits by having the FDA issue a compliance policy guideline prohibiting the use of Estriol. This action is a continuation of the FDA's campaign to ban all bio-identical hormones, Armour Thyroid and all compounded preparations from the market place. Wyeth and its other Big Pharma allies want to destroy compounding pharmacy because it represents competition. The FDA is the hammer used by Wyeth to carry out its objective.
The FDA takes its direction from the pharmaceutical companies which fund the FDA by paying drug user fees on any drugs that the FDA approves. The drug companies provide the FDA with nearly 30% of its funding, accounting for $350 million in this fiscal year alone.
Because the FDA is dependent upon the sale of drugs for a major portion of its income, whose interests do you think it will protect, yours or the drug companies?
Wyeth manufactures Premarin and Prempro, counterfeit hormones derived from pregnant mares’ urine. These drugs were studied in the Women’s Health Initiative which was abruptly halted in 2002 when they were shown to increase the risk of breast cancer, heart disease, blood clots to the lungs, and strokes. Hundreds of thousands of women abandoned Premarin and Prempro causing a dramatic decline in sales for Wyeth amounting to over $500 million per year. This translated into a decline in fees paid by Wyeth to the FDA.
As an alternative, many women sought the safer, natural bio-identical hormones, prescribed by their physicians and prepared by their local community pharmacists. A key ingredient in this compounded preparation was the natural female hormone Estriol, which is produced in every woman beginning at puberty and enables women to develop their menstrual cycles. Estriol has been used by physicians for decades to treat problems associated with peri and post menopausal symptoms. There has never been any adverse event reported to the FDA related to the use of Estriol.
In an attempt to destroy its competition, Wyeth filed a “citizen complaint” with the FDA in 2005 asking the agency to ban the use of Estriol. Over 70,000 patients filed responses with the FDA opposing Wyeth’s attempt to undermine their right to choose natural solutions for their health problems by restricting the use of Estriol. These patients do not believe that some bureaucrat in Washington knows better than their physician as to what medication is best for them.
In January 2008 the FDA issued a compliance policy guideline supporting Wyeth’s request for banning the sale of Estriol to community pharmacies which compound bio-identical preparations. This was another step in the FDA’s attempt to destroy the practice of compounding pharmacy which is regulated by the respective state boards of pharmacy.
A battle for the rights of patients, pharmacists and physicians has begun in earnest in Congress. Texas Congressmen Burgess, Carter, Hall, McCaul, Paul, and Thornberry, among others, have introduced House Concurrent Resolution (H. Con. Res.) 342 in Congress which calls upon the FDA to lift its ban on Estriol.
Senator John Cornyn – (R-Texas) has also sponsored this resolution in the U.S. Senate, titled Senate Concurrent Resolution (S. Con. Res.) 88.
The FDA must not be allowed to be used by the drug companies in their plan to destroy the health rights of millions of Americans who choose the benefits of natural bio-identical hormones and other compounded preparations as an alternative to drugs promoted by Big Pharma.
Action List:
1. Go to the Project FANS website right now, www.projectfans.org, for updated information in our counter attack against the FDA and Wyeth. The House and Senate Resolutions may be downloaded from the website.
2. Contact your local U.S. Congressman and U.S. Senators by phone and by e-mail today. Tellthem that you want them to rescind the FDA's ban on Estriol and support H. Con. Res. 342 and S. Con. Res. 88. Information at www.projectfans.org will enable you to determine your congressman and senators and give you contact information.
3. Get this information to your patients and friends today. Recruit them to join our battle for liberty.
Go to www.projectfans.org to learn more about this issue and what actions you can take to protect your rights.
Our goal is to have 100,000 individuals contact the U.S. Congress by August 1, 2008. This will be a wake up call to the politicians. Remember, they are running for reelection in November, so now is the time for us to strike with maximally concentrated forces.
With the help of Almighty God and through our diligent efforts, I am confident that we can secure our liberty in this crucial matter.
Let's press the battle!
With much appreciation for your commitment to liberty, I remain, as always, Sincerely yours,
Steven F. Hotze, M.D.
Steven F. Hotze, M.D. Chief Executive Hotze Health & Wellness Center www.hotzehwc.com
President, Project F.A.N.S. www.projectfans.org
20214 Braidwood, Suite 215 Katy, Texas 77450 (o) 281.698.8679 - Exec. Asst. - Stacey Bandfield stacey.bandfield@hotzehwc.com
Current List of Legislators Supporting Resolution
House and Senate Members
July 01, 2008
H.CON.RES.342
Title: Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.
Sponsor: Rep Ross, Mike [AR-4] (introduced 5/6/2008) Cosponsors (44)
Latest Major Action: 5/7/2008 Referred to House subcommittee. Status: Referred to the Subcommittee on Health. COSPONSORS(44), ALPHABETICAL [followed by Cosponsors withdrawn]: (Sort: by date)
Rep Allen, Thomas H. [ME-1] - 6/11/2008
Rep Bachus, Spencer [AL-6] - 6/23/2008
Rep Baldwin, Tammy [WI-2] - 5/6/2008
Rep Berry, Marion [AR-1] - 6/4/2008
Rep Bishop, Rob [UT-1] - 6/4/2008
Rep Boozman, John [AR-3] - 6/4/2008
Rep Boren, Dan [OK-2] - 6/20/2008
Rep Boyda, Nancy E. [KS-2] - 6/24/2008
Rep Brown-Waite, Ginny [FL-5] - 6/3/2008
Rep Burgess, Michael C. [TX-26] - 5/6/2008
Rep Burton, Dan [IN-5] - 6/11/2008
Rep Carter, John R. [TX-31] - 5/6/2008
Rep Chandler, Ben [KY-6] - 6/4/2008
Rep Cooper, Jim [TN-5] - 6/11/2008
Rep Doyle, Michael F. [PA-14] - 6/5/2008
Rep Emerson, Jo Ann [MO-8] - 5/6/2008
Rep Eshoo, Anna G. [CA-14] - 6/19/2008
Rep Farr, Sam [CA-17] - 5/6/2008
Rep Franks, Trent [AZ-2] - 6/25/2008
Rep Giffords, Gabrielle [AZ-8] - 5/6/2008
Rep Gohmert, Louie [TX-1] - 6/24/2008
Rep Gonzalez, Charles A. [TX-20] - 6/23/2008
Rep Goode, Virgil H., Jr. [VA-5] - 6/19/2008
Rep Granger, Kay [TX-12] - 6/3/2008
Rep Grijalva, Raul M. [AZ-7] - 6/4/2008
Rep Hall, Ralph M. [TX-4] - 6/3/2008
Rep Kuhl, John R. "Randy", Jr. [NY-29] - 6/4/2008
Rep LaHood, Ray [IL-18] - 6/23/2008
Rep Lofgren, Zoe [CA-16] - 6/11/2008
Rep McCaul, Michael T. [TX-10] - 6/5/2008
Rep Michaud, Michael H. [ME-2] - 6/5/2008
Rep Miller, Jeff [FL-1] - 6/19/2008
Rep Mitchell, Harry E. [AZ-5] - 6/19/2008
Rep Murphy, Tim [PA-18] - 6/11/2008
Rep Musgrave, Marilyn N. [CO-4] - 6/19/2008
Rep Pastor, Ed [AZ-4] - 6/11/2008
Rep Paul, Ron [TX-14] - 5/22/2008
Rep Shays, Christopher [CT-4] - 6/4/2008
Rep Snyder, Vic [AR-2] - 6/5/2008
Rep Stearns, Cliff [FL-6] - 6/4/2008
Rep Thornberry, Mac [TX-13] - 6/3/2008
Rep Wamp, Zach [TN-3] - 5/22/2008
Rep Weller, Jerry [IL-11] - 6/5/2008
Rep Wexler, Robert [FL-19] - 6/4/2008
S.CON.RES.88
Title: A concurrent resolution expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.
Sponsor: Sen Cornyn, John [TX] (introduced 6/10/2008) Cosponsors (2)
Latest Major Action: 6/10/2008 Referred to Senate committee. Status: Referred to the Committee on Health, Education, Labor, and Pensions. COSPONSORS(2), ALPHABETICAL [followed by Cosponsors withdrawn]: (Sort: by date)
Sen Bunning, Jim [KY] - 6/10/2008
Sen Inhofe, James M. [OK] - 6/17/2008
|